An official website of the United States government
NIH Guide: Weekly Index for March 11, 2022
Weekly NIH Guide Notices
March 11, 2022
General Notices
-
RESCINDED - Notice of NIAAA Data-Sharing Guidance for Human Subjects Grants Research Funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [4th Revision]
(NOT-AA-22-011)National Institute on Alcohol Abuse and Alcoholism
-
Notice of NICHD Participation on PAR-21-358 " Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)"
(NOT-HD-22-004)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Clarification of Research Priorities for RFA-NR-22-002, "Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)"
(NOT-NR-22-012)National Institute of Nursing Research
-
Notice Announcing FAQs, Webinar Recording, and Presentation for RFA-NR-22-001 "Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)"
(NOT-NR-22-013)National Institute of Nursing Research
-
The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2022 SGM Research Investigator Awards Program
(NOT-OD-22-088)Office of the Director, NIH
-
Notice of Pre-Application Webinar and Availability of FAQs for RFA-OD-22-003, Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
(NOT-OD-22-089)Office of Disease PreventionNational Institute on Drug Abuse
-
Notice of Pre-Application Webinar and Availability of FAQs for RFA-OD-22-004, Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
(NOT-OD-22-090)Office of Disease PreventionNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Heart, Lung, and Blood Institute
-
Technical Assistance Webinar for PAR 22-115 and PAR 22-120: Research on Community Level Interventions for Firearm and Related Violence Injury and Mortality Prevention (CLIF-VP)
(NOT-OD-22-093)Office of Behavioral and Social Sciences Research
-
Request for Information (RFI) on Capacity and Support Needed to Increase Community-Based Research Networks Participation in Alzheimers Disease and Related Dementias (AD/ADRD) Clinical Trials
(NOT-AG-22-018)National Institute on Aging
-
NIH Request for Information (RFI) on Interdisciplinary Research Opportunities that Bridge Neuroscience and Environmental Health Science
(NOT-NS-22-076)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institute on Drug AbuseNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Behavioral and Social Sciences Research
Notice of Changes to Funding Opportunities
-
Notice of Participation of the National Institute on Aging (NIA) in PAR-20-084 "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)"
(NOT-AG-22-019)National Institute on Aging
-
Notice of Change to Eligibility Information in PAR-22-075, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
(NOT-AI-22-036)National Institute of Allergy and Infectious Diseases
-
Notice of Participation of the National Center for Complementary and Integrative Health (NCCIH) in PAR-21-173, "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
(NOT-AT-22-014)National Center for Complementary and Integrative Health
-
Notice of Participation of the National Center for Complementary and Integrative Health (NCCIH) in PAR-21-169, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
(NOT-AT-22-015)National Center for Complementary and Integrative Health
-
Notice of Correction to Letters of Support Expectations for RFA-MH-22-130, "Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)"
(NOT-MH-22-185)National Institute of Mental Health
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
(NOT-CA-22-061)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention and Control Clinical Trials Planning Grant (U34 Clinical Trials Optional)
(NOT-CA-22-062)National Cancer Institute
Requests for Proposal
-
2022 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2022-1 Now Available
(NOT-AI-22-039)National Institute of Allergy and Infectious Diseases
Funding Opportunities
-
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
(PAR-22-104)John E. Fogarty International CenterNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): Multiple dates, see announcement.
-
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
(PAR-22-107)National Human Genome Research InstituteNational Institute of Mental HealthApplication Receipt Date(s): November 6, 2022
-
International Bioethics Research Training Program (D43 Clinical Trial Optional)
(PAR-22-116)John E. Fogarty International CenterEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteApplication Receipt Date(s): June 6, 2024
-
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
(PAR-22-118)John E. Fogarty International CenterNational Institute of Allergy and Infectious DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteApplication Receipt Date(s): June 6, 2024
-
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
(PAR-22-123)National Institute of Biomedical Imaging and BioengineeringNational Institute on AgingNational Cancer InstituteNational Eye InstituteApplication Receipt Date(s): November 5, 2024
-
NIA Program Project Applications (P01 Clinical Trial Optional)
(PAR-22-130)National Institute on AgingApplication Receipt Date(s): January 7, 2026
-
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
(PAR-22-135)National Eye InstituteApplication Receipt Date(s): December 18, 2024
-
Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)
(RFA-AI-22-019)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): April 19, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
-
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-22-022)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): August 3, 2022
-
Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
(RFA-CA-22-015)National Cancer InstituteApplication Receipt Date(s): July 6, 2022
-
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional)
(RFA-HD-23-007)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): July 27, 2022
-
Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed)
(RFA-MH-22-200)National Institute of Mental HealthApplication Receipt Date(s): October 18, 2022
-
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
(RFA-OD-22-003)Office of Disease PreventionNational Institute on Drug AbuseApplication Receipt Date(s): July 14, 2022
-
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
(RFA-OD-22-004)Office of Disease PreventionNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): July 14, 2022
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster